Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People in Denmark who have metastatic renal cell carcinoma (a type of kidney cancer that has spread to other parts of the body) and are receiving medical treatment for it.
Who may not be able to join:
- People who have not provided written informed consent (a signed document showing agreement to take part in the trial).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Niels Fristrup, MD, PhD, University of Aarhus
Phone: +4520914161
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival (OS); Progression free survival (PFS); Quality of life according to NCCN-FACT FKSI-19.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.